Follow
Gabriela Schneider Rauber
Gabriela Schneider Rauber
Postdoctoral researcher, CATRIN, Palacky University Olomouc, Czechia
Verified email at upol.cz
Title
Cited by
Cited by
Year
Cocrystal formation through mechanochemistry: from neat and liquid‐assisted grinding to polymer‐assisted grinding
D Hasa, G Schneider Rauber, D Voinovich, W Jones
Angewandte Chemie 127 (25), 7479-7483, 2015
2692015
HPMC as a potential enhancer of nimodipine biopharmaceutical properties via ball-milled solid dispersions
MK Riekes, G Kuminek, GS Rauber, CEM de Campos, AJ Bortoluzzi, ...
Carbohydrate polymers 99, 474-482, 2014
542014
Polymorphism of anti-HIV drug efavirenz: investigations on thermodynamic and dissolution properties
C Fandaruff, GS Rauber, AM Araya-Sibaja, RN Pereira, CEM De Campos, ...
Crystal growth & design 14 (10), 4968-4975, 2014
502014
Polymorphism in nimodipine raw materials: development and validation of a quantitative method through differential scanning calorimetry
MK Riekes, RN Pereira, GS Rauber, SL Cuffini, CEM de Campos, ...
Journal of pharmaceutical and biomedical analysis 70, 188-193, 2012
452012
Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy
ACR de Moraes, CK Maranho, GS Rauber, MC Santos‐Silva
Journal of clinical laboratory analysis 27 (1), 62-71, 2013
402013
Single crystal structure, solid state characterization and dissolution rate of terbinafine hydrochloride
G Kuminek, GS Rauber, MK Riekes, CEM de Campos, GA Monti, ...
Journal of pharmaceutical and biomedical analysis 78, 105-111, 2013
392013
Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process
AS Paulino, G Rauber, CEM Campos, MHP Maurício, RR De Avillez, ...
European Journal of Pharmaceutical Sciences 49 (2), 294-301, 2013
312013
Implications of the conformationally flexible, macrocyclic structure of the first-generation, direct-acting anti-viral paritaprevir on its solid form complexity and chameleonic …
AY Sheikh, A Mattei, R Miglani Bhardwaj, RS Hong, NS Abraham, ...
Journal of the American Chemical Society 143 (42), 17479-17491, 2021
272021
Mechanochemical formation of racemic praziquantel hemihydrate with improved biopharmaceutical properties
D Zanolla, D Hasa, M Arhangelskis, G Schneider-Rauber, MR Chierotti, ...
Pharmaceutics 12 (3), 289, 2020
272020
Cocristais: uma estratégia promissora na área farmacêutica
ABO Rocha, G Kuminek, TC Machado, J Rosa, GS Rauber, PAA Borba, ...
Química Nova 39, 1112-1125, 2016
232016
Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study
AM Araya-Sibaja, AS Paulino, GS Rauber, CEM Campos, SG Cardoso, ...
Pharmaceutical Development and Technology 19 (7), 779-788, 2014
212014
Dehydration without heating: use of polymer-assisted grinding for understanding the stability of hydrates in the presence of polymeric excipients
D Scaramuzza, G Schneider Rauber, D Voinovich, D Hasa
Crystal Growth & Design 18 (9), 5245-5253, 2018
182018
Emerging technologies to target drug delivery to the skin–the role of crystals and carrier-based systems in the case study of dapsone
G Schneider-Rauber, DF Argenta, T Caon
Pharmaceutical Research 37, 1-21, 2020
172020
On the kinetics of solvate formation through mechanochemistry
D Hasa, M Pastore, M Arhangelskis, B Gabriele, AJ Cruz-Cabeza, ...
CrystEngComm 21 (13), 2097-2104, 2019
162019
Hollow crystal anti-solvent preparation process as a promising technique to improve dissolution of poorly soluble drugs
AS Paulino, GS Rauber, CEM Campos, MHP Maurício, RR de Avillez, ...
Journal of crystal growth 366, 76-81, 2013
152013
Development and validation of an intrinsic dissolution method for nimodipine polymorphs
M Riekes, G Kuminek, G Rauber, S Cuffini, H Stulzer
Open Chemistry 12 (5), 549-556, 2014
132014
Determination of nimodipine in the presence of its degradation products and overall kinetics through a stability-indicating LC method
MK Riekes, GS Rauber, G Kuminek, MP Tagliari, SG Cardoso, HK Stulzer
Journal of chromatographic science 51 (6), 511-516, 2013
132013
How to define the experimental conditions of skin permeation assays for drugs presenting biopharmaceutical limitations? The experience with testosterone
NE Biondo, DF Argenta, GS Rauber, T Caon
International Journal of Pharmaceutics 607, 120987, 2021
112021
Development and characterization of thermopressed polyvinyl alcohol films for buccal delivery of benznidazole
BR Amaral, RH Saatkamp, AE Junior, R Kroth, DF Argenta, ...
Materials Science and Engineering: C 119, 111546, 2021
112021
An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications
ERL Rebelatto, GS Rauber, T Caon
International Journal of Pharmaceutics 635, 122727, 2023
92023
The system can't perform the operation now. Try again later.
Articles 1–20